Taming neonatal hypoxic-ischemic brain injury by intranasal delivery of plasminogen activator inhibitor-1

Stroke

Volumn 44, Issue 9, 2013, Pages 2623-2627

  Yang, Dianer ^a,b   Sun, Yu Yo ^a,b   Lin, Xiaoyi ^b   Baumann, Jessica M ^a   Warnock, Mark ^c   Lawrence, Daniel A ^c   Kuan, Chia Yi ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Chorioamnionitis; Hypothermia; Hypoxic ischemic encephalopathy; Intrauterine infection; Neonatal encephalopathy; Tissue type plasminogen activator

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ATROPHY; BRAIN CORTEX; CONTROLLED STUDY; EXPERIMENTAL THERAPY; FEMALE; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOBLOTTING; MALE; NERVOUS SYSTEM INFLAMMATION; NEWBORN; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL; RAT; WISTAR RAT;

CHORIOAMNIONITIS; HYPOTHERMIA; HYPOXIC-ISCHEMIC ENCEPHALOPATHY; INTRAUTERINE INFECTION; NEONATAL ENCEPHALOPATHY; TISSUE-TYPE PLASMINOGEN ACTIVATOR;

ADMINISTRATION, INTRANASAL; ANIMALS; ANIMALS, NEWBORN; ATROPHY; BLOOD-BRAIN BARRIER; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HYPOXIA-ISCHEMIA, BRAIN; MALE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN INACTIVATORS; RATS; RATS, WISTAR; SERINE PROTEINASE INHIBITORS;

EID: 84884500795     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.001233     Document Type: Article

References (12)

1. Kaur J, Zhao Z, Klein GM, Lo EH, Buchan AM. The neurotoxicity of tissue plasminogen activator? J Cereb Blood Flow Metab. 2004;24:945-963.
2. Wang X, Tsuji K, Lee SR, Ning M, Furie KL, Buchan AM, et al. Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke. 2004;35(11 suppl 1):2726-2730.
3. Yang D, Nemkul N, Shereen A, Jone A, Dunn RS, Lawrence DA, et al. Therapeutic administration of plasminogen activator inhibitor-1 prevents hypoxic-ischemic brain injury in newborns. J Neurosci. 2009;29:8669-8674.
4. Yang D, Sun YY, Nemkul N, Baumann JM, Shereen A, Dunn RS, et al. Plasminogen activator inhibitor-1 mitigates brain injury in a rat model of infection-sensitized neonatal hypoxia-ischemia. Cereb Cortex. 2013;23:1218-1229.
5. Berkenpas MB, Lawrence DA, Ginsburg D. Molecular evolution of plasminogen activator inhibitor-1 functional stability. EMBO J. 1995;14:2969-2977.
6. Eklind S, Mallard C, Arvidsson P, Hagberg H. Lipopolysaccharide induces both a primary and a secondary phase of sensitization in the developing rat brain. Pediatr Res. 2005;58:112-116.
7. Dhuria SV, Hanson LR, Frey WH II. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci. 2010;99:1654-1673.
8. Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol. 2012;69:29-38.
9. Yang D, Sun YY, Lin X, Baumann JM, Dunn RS, Lindquist DM, et al. Intranasal delivery of cell-penetrating anti-NF-kB peptides (Tat-NBD) alleviates infection-sensitized hypoxic-ischemic brain injury. Exp Neurol. January 23, 2013. doi: 10.1016/j.expneurol.2013.01.015.
10. Sun YY, Yang D, Kuan CY. Mannitol-facilitated perfusion staining with 2,3,5-triphenyltetrazolium chloride (TTC) for detection of experimental cerebral infarction and biochemical analysis. J Neurosci Methods. 2012;203:122-129.
11. Wintermark P, Boyd T, Gregas MC, Labrecque M, Hansen A. Placental pathology in asphyxiated newborns meeting the criteria for therapeutic hypothermia. Am J Obstet Gynecol. 2010;203:579.e1-579.e9.
12. Li Y, Field PM, Raisman G. Olfactory ensheathing cells and olfactory nerve fibroblasts maintain continuous open channels for regrowth of olfactory nerve fibres. Glia. 2005;52:245-251.